Athersys plans to sell $12 million in securities to raise cash for operations


The move comes amid financial and operational restructuring at the regenerative medicine company.

Previous Workforce shortage puts nurses in strong position while negotiating contracts
Next Popular Portland brewer expands restaurant portfolio with NE Portland eatery